Source: Eur Respir Rev, 27 (147) 170113; 10.1183/16000617.0113-2017
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Panagiotis Paliogiannis, Alessandro G. Fois, Salvatore Sotgia, Arduino A. Mangoni, Elisabetta Zinellu, Pietro Pirina, Silvia Negri, Ciriaco Carru, Angelo Zinellu. Neutrophil to lymphocyte ratio and clinical outcomes in COPD: recent evidence and future perspectives. Eur Respir Rev, 27 (147) 170113; 10.1183/16000617.0113-2017

Member's Comments

No comment yet.

Related content which might interest you: T-cell biology and eosinophils in asthma: clinical implications Source: International Congress 2019 – It takes two to tango: translating scientific findings into clinical applications Year: 2019 Neutrophil to lymphocyte ratio and severity of COPD : prospective study Source: Virtual Congress 2021 – New insights into the airway immunology of lung disease Year: 2021 Assessing the effect of medical therapy in COPD: from pathophysiology and biomarkers to clinical practice Source: Annual Congress 2009 - PG15 The complexity of COPD: assessment and advanced therapies Year: 2009 Laboratory investigations of infection in COPD: current best practice and future possibilities Source: Annual Congress 2008 - PG1 - EU GRACE network full-day course: Antibiotics or not: from acute bronchitis to acute exacerbation of chronic bronchitis Year: 2008 Clinical trial landscape for M/XDR-TB: current evidence and future perspectives Source: International Congress 2019 – Recent developments and future perspectives in the diagnosis and treatment of tuberculosis Year: 2019 Emerging concepts in outcome assessment for COPD clinical trials Source: Annual Congress 2007 - PG13 - Outcome measures of clinical trials for new drugs for respiratory disease Year: 2007 Genetic testing in pulmonary hypertension: how should our clinical practice reflect recent advances? Source: Eur Respir J 2016; 47: 388-389 Year: 2016 Future prospects of translational and clinical eosinophil research Source: Eur Respir Monogr 2022; 95: 253-262 Year: 2022 A new era in idiopathic pulmonary fibrosis: considerations for future clinical trials Source: Eur Respir J 2015; 46: 243-249 Year: 2015 What is a COPD exacerbation? Current definitions, pitfalls, challenges and opportunities for improvement Source: Eur Respir J, 52 (5) 1801261; 10.1183/13993003.01261-2018 Year: 2018 Measuring inflammation inpaediatric severe asthma: biomarkers in clinical practice Source: Breathe, 16 (1) 190301; 10.1183/20734735.0301-2019 Year: 2020 Lung function trajectory research: historical perspective and future prospects Source: Research Seminar 2021 – Lung function trajectories from birth to death, health and disease, and pre-war to today Year: 2021 COVID-19 and COPD: a narrative review of the basic science and clinical outcomes Source: Eur Respir Rev, 29 (158) 200199; 10.1183/16000617.0199-2020 Year: 2020 Early detection of COPD in general practice: preliminary observations Source: Annual Congress 2009 - Exacerbations and characteristics of COPD Year: 2009 Emerging challenges to the development and implementation of clinical practice guidelines – COPD as a case in point Source: Annual Congress 2008 - Guideline development workshop summary: ATS/ERS integrating and coordinating efforts in COPD Year: 2008